Titre : Lactoyl glutathione lyase

Lactoyl glutathione lyase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prediabetic State
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lactoyl glutathione lyase : Questions médicales les plus fréquentes", "headline": "Lactoyl glutathione lyase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lactoyl glutathione lyase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-19", "dateModified": "2025-02-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lactoyl glutathione lyase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carbon-sulfur lyases", "url": "https://questionsmedicales.fr/mesh/D013437", "about": { "@type": "MedicalCondition", "name": "Carbon-sulfur lyases", "code": { "@type": "MedicalCode", "code": "D013437", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.520.300" } } }, "about": { "@type": "MedicalCondition", "name": "Lactoyl glutathione lyase", "alternateName": "Lactoylglutathione Lyase", "code": { "@type": "MedicalCode", "code": "D007791", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yu-Zhong Zhang", "url": "https://questionsmedicales.fr/author/Yu-Zhong%20Zhang", "affiliation": { "@type": "Organization", "name": "College of Marine Life Sciences, Frontiers Science Center for Deep Ocean Multispheres and Earth System, Ocean University of China, Qingdao 266003, China." } }, { "@type": "Person", "name": "Julie D Saba", "url": "https://questionsmedicales.fr/author/Julie%20D%20Saba", "affiliation": { "@type": "Organization", "name": "Children's Hospital Oakland Research Institute, University of California, San Francisco Benioff Children's Hospital Oakland, Oakland, CA 94609 jsaba@chori.org." } }, { "@type": "Person", "name": "Lidia de Bari", "url": "https://questionsmedicales.fr/author/Lidia%20de%20Bari", "affiliation": { "@type": "Organization", "name": "Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies-CNR, Via G. Amendola 122/O, 70126 Bari, Italy." } }, { "@type": "Person", "name": "Marissa N Trujillo", "url": "https://questionsmedicales.fr/author/Marissa%20N%20Trujillo", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Erin Q Jennings", "url": "https://questionsmedicales.fr/author/Erin%20Q%20Jennings", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[Prediabetes as a therapeutic challenge in internal medicine].", "datePublished": "2023-06-16", "url": "https://questionsmedicales.fr/article/37328664", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00108-023-01546-6" } }, { "@type": "ScholarlyArticle", "name": "Diabetes and prediabetes in children with cystic fibrosis.", "datePublished": "2023-06-02", "url": "https://questionsmedicales.fr/article/37211992", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MOP.0000000000001259" } }, { "@type": "ScholarlyArticle", "name": "The Role of Prediabetes in the Metabolic Syndrome: Guilt by Association.", "datePublished": "2023-04-11", "url": "https://questionsmedicales.fr/article/37042661", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1089/met.2023.0005" } }, { "@type": "ScholarlyArticle", "name": "[Design and development of a dietary intervention in children with prediabetes].", "datePublished": "2022-09-16", "url": "https://questionsmedicales.fr/article/36122505", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.semerg.2022.101814" } }, { "@type": "ScholarlyArticle", "name": "Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes.", "datePublished": "2022-07-03", "url": "https://questionsmedicales.fr/article/35787415", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.diabres.2022.109980" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Lyases", "item": "https://questionsmedicales.fr/mesh/D008190" }, { "@type": "ListItem", "position": 5, "name": "Carbon-sulfur lyases", "item": "https://questionsmedicales.fr/mesh/D013437" }, { "@type": "ListItem", "position": 6, "name": "Lactoyl glutathione lyase", "item": "https://questionsmedicales.fr/mesh/D007791" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lactoyl glutathione lyase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lactoyl glutathione lyase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lactoyl glutathione lyase", "description": "Comment diagnostiquer une déficience en lactoyl glutathione lyase ?\nQuels tests sont utilisés pour évaluer l'activité de cette enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nY a-t-il des biomarqueurs associés à cette enzyme ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés à cette enzyme ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Prediabetic+State&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lactoyl glutathione lyase", "description": "Quels sont les symptômes d'une déficience en lactoyl glutathione lyase ?\nLa déficience peut-elle causer des problèmes cutanés ?\nY a-t-il des symptômes digestifs associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on observer des symptômes psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Prediabetic+State&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lactoyl glutathione lyase", "description": "Comment prévenir les complications liées à cette enzyme ?\nY a-t-il des tests de dépistage recommandés ?\nLes antioxydants peuvent-ils prévenir des problèmes ?\nEst-il important de gérer le stress ?\nLes vaccinations sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Prediabetic+State&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lactoyl glutathione lyase", "description": "Quels traitements sont disponibles pour la déficience en lactoyl glutathione lyase ?\nLa thérapie génique est-elle une option ?\nDes changements alimentaires peuvent-ils aider ?\nY a-t-il des médicaments spécifiques à éviter ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Prediabetic+State&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lactoyl glutathione lyase", "description": "Quelles complications peuvent survenir avec cette déficience ?\nLa déficience peut-elle affecter le système immunitaire ?\nY a-t-il des risques de maladies chroniques ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Prediabetic+State&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lactoyl glutathione lyase", "description": "Quels sont les facteurs de risque pour cette déficience ?\nL'âge joue-t-il un rôle dans le risque ?\nY a-t-il des maladies associées à ce risque ?\nLe mode de vie influence-t-il le risque ?\nLes facteurs environnementaux sont-ils significatifs ?", "url": "https://questionsmedicales.fr/mesh/D007791?mesh_terms=Prediabetic+State&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en lactoyl glutathione lyase ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent confirmer la déficience." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité de cette enzyme ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques mesurant l'activité enzymatique dans des échantillons biologiques." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes de stress oxydatif, comme la fatigue ou des troubles neurologiques." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs associés à cette enzyme ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de glutathion et de lactate peuvent être des biomarqueurs." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés à cette enzyme ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en lactoyl glutathione lyase ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, troubles neurologiques, et susceptibilité accrue aux infections." } }, { "@type": "Question", "name": "La déficience peut-elle causer des problèmes cutanés ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des éruptions cutanées et une sensibilité accrue peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des symptômes digestifs associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles digestifs comme des nausées peuvent être présents." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les jeunes enfants." } }, { "@type": "Question", "name": "Peut-on observer des symptômes psychologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de l'humeur et de l'anxiété peuvent être liés à cette déficience." } }, { "@type": "Question", "name": "Comment prévenir les complications liées à cette enzyme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain et une alimentation équilibrée peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Y a-t-il des tests de dépistage recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de dépistage génétique peuvent être recommandés pour les familles à risque." } }, { "@type": "Question", "name": "Les antioxydants peuvent-ils prévenir des problèmes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation adéquate d'antioxydants peut réduire le stress oxydatif." } }, { "@type": "Question", "name": "Est-il important de gérer le stress ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gestion du stress est cruciale pour maintenir une bonne santé cellulaire." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir les infections chez les personnes à risque." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la déficience en lactoyl glutathione lyase ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments de glutathion et des antioxydants peuvent être recommandés." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore largement disponible." } }, { "@type": "Question", "name": "Des changements alimentaires peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en antioxydants peut soutenir la santé cellulaire." } }, { "@type": "Question", "name": "Y a-t-il des médicaments spécifiques à éviter ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments oxydants doivent être évités pour réduire le stress oxydatif." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés selon la gravité des symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec cette déficience ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections récurrentes et des troubles neurologiques peuvent survenir." } }, { "@type": "Question", "name": "La déficience peut-elle affecter le système immunitaire ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut affaiblir le système immunitaire, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies chroniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un stress oxydatif accru peut contribuer à des maladies chroniques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications potentielles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour cette déficience ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux et des expositions environnementales peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants sont plus susceptibles de présenter des déficiences enzymatiques." } }, { "@type": "Question", "name": "Y a-t-il des maladies associées à ce risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies métaboliques peuvent être liées à un risque accru de déficience." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie malsain peut augmenter le risque de complications liées à cette enzyme." } }, { "@type": "Question", "name": "Les facteurs environnementaux sont-ils significatifs ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut augmenter le risque de déficience." } } ] } ] }

Sources (10000 au total)

Diabetes and prediabetes in children with cystic fibrosis.

Glucose metabolism alterations in cystic fibrosis range from the classic cystic fibrosis-related diabetes (CFRD) to forms of glucose intolerance and prediabetes. The aim of the present work is to revi... Confirm that Oral Glucose Tolerance Test is still the diagnostic gold standard despite the advent of continuous glucose monitoring (CGM) systems; this latter is spreading very rapidly, however, to dat... Tailored and personalized insulin therapy is still the recommended therapy for children and adolescents with CFRD, although nutritional intervention and oral hypoglycaemic treatment are equally import...

[Design and development of a dietary intervention in children with prediabetes].

Prediabetes is a pathological condition where the blood glucose concentration is higher than normal concentrations, but lower than those considered in the diagnosis of type 2 diabetes mellitus (DM2). ... In our study, 29 pre-diabetic children from Pedro Abad, Córdoba, have been evaluated. For this, we have carried out a randomized crossover trial with an intervention group (IG) and a control group (CG... Through a nutritional evaluation through different tests and visits made to the children, the results corresponding to the first phase of the study, relate an improvement in eating habits and adherenc... The eating habits of pre-diabetic children improve with a dietary intervention based on nutritional education, since by providing them with knowledge of the different foods and the contribution of nut...

The prevalence of diabetes and prediabetes: a population-based study.

Diabetes remains one of the top public health care priorities. Over 6% of the world's population is affected by type 2 diabetes; however, a similar number of individuals may be unaware of this diagnos... Our population‑basedstudy aimed to investigate the true prevalence of diabetes and prediabetes in the general population of a medium‑sized city in Poland.... The analysis included 1051 participants of the Bialystok PLUS population‑based cohort study. In those who did not report a history of diabetes, the oral glucose tolerance test (OGTT) was performed. Me... According to the medical history data, a total of 75 participants had diabetes (7.14%). Prediabetes (impaired fasting glycemia [IFG] or impaired glucose tolerance [IGT]) was identified in 410 individu... Our cohort study demonstrated a high prevalence of undiagnosed diabetes in the Białystok population. In addition, we showed that a large group of patients still remains undiagnosed for other hyperglyc...

The role of irisin and asprosin level in the pathophysiology of prediabetes.

We aimed to examine whether irisin and asprosin have a role in the physiopathology of prediabetes.... Hundred people were selected between the age of 18-65 years for the study population (60 prediabetes, 40 healthy). For the follow-up study, the patients with prediabetes were offered a 3-month program... Among the healthy group and patients with prediabetes, irisin levels were lower and asprosin levels were higher (p < 0.001) in patients. In the follow-up part, the patients' insulin levels, HOMA index... Both irisin and asprosin have been found to be related to the prediabetes pathway and it has been shown that these molecules may be useful in daily clinical practice with diagnostic performances simil...

Association between prediabetes and depression: A meta-analysis.

Previous studies evaluating the association between prediabetes and depression have shown inconsistent results. Consequently, the aim of the systematic review and meta-analysis was to investigate whet... Relevant observational studies were obtained by searching the Medline, Web of Science, and Embase databases. A random-effects model was utilized to pool the results by incorporating the influence of h... Sixteen large-scale cross-sectional studies involving 322,863 participants were included. Among the total participants, 82,154 (25.4%) had prediabetes. The pooled results showed that prediabetes was a... Prediabetes may be associated with a slightly higher prevalence of depression in the general population, particularly in subjects aged <50 years old....

[Associated factors for prediabetes in patients with human immunodeficiency virus].

HIV disease was transformed from a fatal condition to one with metabolic complications. In Mexico City, the associated factors for prediabetes in this population are unknown; investigating it is relev... To determine the risk association factors for prediabetes in people living with HIV.... Cross-analytical, retrospective study. Records of patients living with HIV were reviewed, exposure factors and fasting glucose concentration were recorded. Patients from 18 to 65 years of age were inc... 148 patients were included, 68 presented prediabetes. The factors with risk association that were identified are: age over 60 years (OR 9.48, 95% CI 1.68-40.13), treatment with Efavirenz/Tenofovir/Emt... The prevalence of prediabetes in people living with HIV is 46%. The main associated factor was the consumption of Atripla. This study has clinical relevance since it will allow the implementation of p...